Color perception and compensation in color deficiencies assessed with hue scaling.


Journal

Vision research
ISSN: 1878-5646
Titre abrégé: Vision Res
Pays: England
ID NLM: 0417402

Informations de publication

Date de publication:
06 2021
Historique:
received: 10 09 2020
revised: 07 12 2020
accepted: 14 01 2021
pubmed: 27 2 2021
medline: 27 1 2022
entrez: 26 2 2021
Statut: ppublish

Résumé

Anomalous trichromats have three classes of cone receptors but with smaller separation in the spectral sensitivities of their longer-wave (L or M) cones compared to normal trichromats. As a result, the differences in the responses of the longer-wave cones are smaller, resulting in a weaker input to opponent mechanisms that compare the LvsM responses. Despite this, previous studies have found that their color percepts are more similar to normal trichromats than the smaller LvsM differences predict, suggesting that post-receptoral processes might amplify their responses to compensate for the weaker opponent inputs. We evaluated the degree and form of compensation using a hue-scaling task, in which the appearance of different hues is described by the perceived proportions of red-green or blue-yellow primary colors. The scaling functions were modeled to estimate the relative salience of the red-green to blue-yellow components. The red-green amplitudes of the 10 anomalous observers were 1.5 times weaker than for a group of 26 normal controls. However, their relative sensitivity at threshold for detecting LvsM chromatic contrast was on average 6 times higher, consistent with a 4-fold gain in the suprathreshold hue-scaling responses. Within-observer variability in the settings was similar for the two groups, suggesting that the suprathreshold gain did not similarly amplify the noise, at least for the dimension of hue. While the compensation was pronounced it was nevertheless partial, and anomalous observers differed systematically from the controls in the shapes of the hue-scaling functions and the corresponding loci of their color categories. Factor analyses further revealed different patterns of individual differences between the groups. We discuss the implications of these results for understanding both the processes of compensation for a color deficiency and the limits of these processes.

Identifiants

pubmed: 33636681
pii: S0042-6989(21)00023-7
doi: 10.1016/j.visres.2021.01.006
pmc: PMC8058247
mid: NIHMS1667174
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-15

Subventions

Organisme : NEI NIH HHS
ID : R01 EY010834
Pays : United States
Organisme : NEI NIH HHS
ID : R29 EY010834
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Références

J Opt Soc Am A Opt Image Sci Vis. 2006 Jul;23(7):1586-97
pubmed: 16783421
Neuron. 2002 Aug 15;35(4):783-92
pubmed: 12194876
Annu Rev Psychol. 1982;33:41-85
pubmed: 6977310
J Opt Soc Am. 1959 Sep;49:890-8
pubmed: 14406629
J Vis. 2014 Nov 20;14(13):19
pubmed: 25413625
J Vis. 2013 Jul 17;13(8):
pubmed: 23863508
J Opt Soc Am A Opt Image Sci Vis. 2000 Mar;17(3):607-14
pubmed: 10708042
Vision Res. 1975 Jun;15(6):723-31
pubmed: 1138490
Neuroimage. 2016 Sep;138:211-220
pubmed: 27150230
J Opt Soc Am A Opt Image Sci Vis. 2014 Apr 1;31(4):A195-207
pubmed: 24695170
Curr Biol. 2020 Aug 3;30(15):3011-3015.e4
pubmed: 32589909
Curr Opin Behav Sci. 2019 Dec;30:28-33
pubmed: 32832586
Psychol Sci. 2005 Apr;16(4):321-7
pubmed: 15828980
J Opt Soc Am. 1977 Feb;67(2):213-20
pubmed: 300100
Vis Neurosci. 2001 Nov-Dec;18(6):901-6
pubmed: 12020080
J Opt Soc Am. 1977 Sep;67(9):1196-1209
pubmed: 409816
Vision Res. 2011 Oct 15;51(20):2224-33
pubmed: 21893078
J Opt Soc Am. 1979 Aug;69(8):1183-6
pubmed: 490231
J Opt Soc Am A Opt Image Sci Vis. 2000 Sep;17(9):1535-44
pubmed: 10975363
J Opt Soc Am A Opt Image Sci Vis. 2008 Nov;25(11):2817-25
pubmed: 18978861
Annu Rev Vis Sci. 2015 Nov 1;1:547-567
pubmed: 26858985
J Physiol. 1984 Dec;357:241-65
pubmed: 6512691
Vision Res. 2004 Nov;44(24):2843-55
pubmed: 15342228
PLoS Comput Biol. 2014 Jun 26;10(6):e1003652
pubmed: 24967877
Vision Res. 1999 May;39(10):1823-31
pubmed: 10343874
Vision Res. 1994 Aug;34(15):1993-2020
pubmed: 7941399
Percept Psychophys. 1994 Jul;56(1):27-41
pubmed: 8084730
Ophthalmic Physiol Opt. 2010 Sep;30(5):602-10
pubmed: 20883345
Vision Res. 1995 Mar;35(6):739-56
pubmed: 7740766
J Opt Soc Am A. 1988 Oct;5(10):1722-35
pubmed: 3204435
Nature. 1993 Jan 28;361(6410):348-50
pubmed: 8426653
Neuron. 2004 Apr 8;42(1):155-62
pubmed: 15066272
Vision Res. 2017 Dec;141:4-15
pubmed: 29129731
Eur J Neurosci. 1997 Jul;9(7):1536-41
pubmed: 9240412
Vision Res. 1991;31(12):2185-93
pubmed: 1771798
Vision Res. 2011 Apr 13;51(7):633-51
pubmed: 21167193
Proc Biol Sci. 2010 Jun 22;277(1689):1817-25
pubmed: 20147325
Vision Res. 1995 Mar;35(5):613-20
pubmed: 7900300
Curr Biol. 2021 Mar 8;31(5):936-942.e4
pubmed: 33326771
PLoS One. 2012;7(9):e46361
pubmed: 23050021
Vision Res. 1978;18(11):1521-32
pubmed: 310193
J Opt Soc Am A. 1993 Jun;10(6):1283-93
pubmed: 8320586
Vis Neurosci. 2006 May-Aug;23(3-4):297-309
pubmed: 16961961
Annu Rev Vis Sci. 2017 Sep 15;3:343-363
pubmed: 28723311
J Vis. 2009 Feb 25;9(2):20.1-16
pubmed: 19271930
Proc Biol Sci. 2016 May 25;283(1831):
pubmed: 27226474
Clin Exp Optom. 2018 Jan;101(1):69-72
pubmed: 28636141
PLoS One. 2011;6(11):e27031
pubmed: 22073247
Annu Rev Psychol. 1994;45:451-85
pubmed: 8135508
J Opt Soc Am A Opt Image Sci Vis. 2020 Apr 1;37(4):A133-A144
pubmed: 32400533
Vision Res. 2021 Mar 25;184:14-22
pubmed: 33773293
Vis Neurosci. 2006 May-Aug;23(3-4):637-43
pubmed: 16962007
Sens Processes. 1978 Jun;2(2):146-55
pubmed: 309656
J Opt Soc Am A Opt Image Sci Vis. 2020 Apr 1;37(4):A44-A54
pubmed: 32400515
Vis Neurosci. 2006 May-Aug;23(3-4):611-6
pubmed: 16962004
Vision Res. 1982;22(9):1123-31
pubmed: 7147723
J Vis. 2007 Jun 18;7(8):6
pubmed: 17685813
Neuron. 2009 Dec 10;64(5):605-16
pubmed: 20005818
J Opt Soc Am A Opt Image Sci Vis. 2020 Apr 1;37(4):V1-V14
pubmed: 32400510
J Opt Soc Am A Opt Image Sci Vis. 2007 Oct;24(10):3168-79
pubmed: 17912307
Psychol Res. 1982;44(2):147-63
pubmed: 6983082
Vision Res. 2017 Dec;141:51-65
pubmed: 28025051
Vision Res. 2008 Aug;48(17):1812-9
pubmed: 18602656
Am J Psychol. 1973 Mar;86(1):115-31
pubmed: 4542659
J Physiol. 1975 Nov;252(3):627-56
pubmed: 1206570
Nat Neurosci. 1999 Oct;2(10):884-8
pubmed: 10491608
J Vis. 2013 Jan 16;13(1):
pubmed: 23325346
Vision Res. 1997 Apr;37(7):885-97
pubmed: 9156186
Fac Rev. 2020 Nov 13;9:8
pubmed: 33659940
J Neurosci. 1990 Feb;10(2):649-69
pubmed: 2303866
Curr Biol. 2015 Mar 2;25(5):R188-9
pubmed: 25734264
J Vis. 2015;15(16):5
pubmed: 26641948
Vision Res. 2017 Dec;141:66-75
pubmed: 28042057
J Opt Soc Am A Opt Image Sci Vis. 2012 Feb 1;29(2):A108-17
pubmed: 22330367
Front Psychol. 2014 Dec 09;5:1416
pubmed: 25538665
Vision Res. 2000;40(13):1711-37
pubmed: 10814758
Vision Res. 2005 Nov;45(25-26):3210-23
pubmed: 16087209
J Opt Soc Am A Opt Image Sci Vis. 2000 Sep;17(9):1545-55
pubmed: 10975364

Auteurs

Kara J Emery (KJ)

Graduate Program in Integrative Neuroscience and Department of Psychology, University of Nevada, Reno, Reno, NV 89557, United States.

Mohana Kuppuswamy Parthasarathy (M)

Graduate Program in Integrative Neuroscience and Department of Psychology, University of Nevada, Reno, Reno, NV 89557, United States.

Daniel S Joyce (DS)

Graduate Program in Integrative Neuroscience and Department of Psychology, University of Nevada, Reno, Reno, NV 89557, United States.

Michael A Webster (MA)

Graduate Program in Integrative Neuroscience and Department of Psychology, University of Nevada, Reno, Reno, NV 89557, United States. Electronic address: mwebster@unr.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH